跳至主要内容
临床试验/IRCT2017072333551N2
IRCT2017072333551N2已完成2 期

Clinical trial of the effect of combined probiotic and vitamin D supplementation compared with the placebo on Clinical symptom and metabolic profiles in schizophrenia patients

Vice chancellor for research, Kashan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 65 years(—)
性别
All

入选标准

  • Diagnosed with schizophrenia using DSM-IV-TR criteria
  • PANSS score of 55 or greater
  • Treated with chlorpromazine (300–1000mg/day, except clozapine) and agents anti-cholinergic (Trihexyphenidyl, 4–8 mg/day) during the last 6 months
  • Aged 25–65 years old
  • Disease duration of at least two years

排除标准

  • Mental retardation
  • Substance or alcohol addiction (except caffeine or nicotine) with in the last 6 months of screening
  • A score of=14 on a 17-item Hamilton Depression Rating Scale or a score of =4 on PANSS (depression item)
  • Under treatment with lithium, carbamazepine and sodium valproic acid
  • Existing chronic and acute medical illness
  • Lactation or pregnancy
  • The use of anti-depressants including MAO, TCA, SSRI in the last 6 months

研究者

发起方
Vice chancellor for research, Kashan University of Medical Sciences

相似试验